Jonathan Beesley

3.3k total citations
16 papers, 350 citations indexed

About

Jonathan Beesley is a scholar working on Cancer Research, Molecular Biology and Genetics. According to data from OpenAlex, Jonathan Beesley has authored 16 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Jonathan Beesley's work include BRCA gene mutations in cancer (5 papers), DNA Repair Mechanisms (3 papers) and Genetic factors in colorectal cancer (3 papers). Jonathan Beesley is often cited by papers focused on BRCA gene mutations in cancer (5 papers), DNA Repair Mechanisms (3 papers) and Genetic factors in colorectal cancer (3 papers). Jonathan Beesley collaborates with scholars based in Australia, United States and United Kingdom. Jonathan Beesley's co-authors include Georgia Chenevix‐Trench, Penelope M. Webb, Amanda B. Spurdle, Sharon E. Johnatty, Shahina Pardhan, Xiaohong Chen, Anna DeFazio, John L. Hopper, Robert Brown and Sián Fereday and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and PLoS Genetics.

In The Last Decade

Jonathan Beesley

15 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Beesley Australia 10 166 125 82 66 65 16 350
Hyewon Chung South Korea 13 177 1.1× 116 0.9× 72 0.9× 186 2.8× 58 0.9× 26 538
Bibo Yuan China 9 270 1.6× 141 1.1× 36 0.4× 37 0.6× 53 0.8× 17 465
Marten van der Zee Netherlands 13 206 1.2× 104 0.8× 65 0.8× 152 2.3× 97 1.5× 15 552
Ulrika W. Nilsson Sweden 9 196 1.2× 89 0.7× 124 1.5× 25 0.4× 128 2.0× 10 398
N A Sheth India 11 132 0.8× 68 0.5× 42 0.5× 37 0.6× 32 0.5× 28 353
Jian Gu China 10 167 1.0× 71 0.6× 24 0.3× 33 0.5× 61 0.9× 20 310
J. Lahodny Austria 7 76 0.5× 116 0.9× 23 0.3× 102 1.5× 41 0.6× 13 366
Elizabeth Jordan United States 11 220 1.3× 95 0.8× 30 0.4× 31 0.5× 68 1.0× 23 522
Valentina Sini Italy 13 63 0.4× 242 1.9× 53 0.6× 42 0.6× 106 1.6× 25 399
Agnieszka Chrobak Poland 13 136 0.8× 36 0.3× 69 0.8× 151 2.3× 24 0.4× 21 434

Countries citing papers authored by Jonathan Beesley

Since Specialization
Citations

This map shows the geographic impact of Jonathan Beesley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Beesley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Beesley more than expected).

Fields of papers citing papers by Jonathan Beesley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Beesley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Beesley. The network helps show where Jonathan Beesley may publish in the future.

Co-authorship network of co-authors of Jonathan Beesley

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Beesley. A scholar is included among the top collaborators of Jonathan Beesley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Beesley. Jonathan Beesley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Stutz, Michael D., Alexander P. Sobinoff, Christopher G. Tomlinson, et al.. (2015). A Common Cancer Risk-Associated Allele in the hTERT Locus Encodes a Dominant Negative Inhibitor of Telomerase. PLoS Genetics. 11(6). e1005286–e1005286. 35 indexed citations
2.
Dixon‐Suen, Suzanne C., Torukiri I Ibiebele, Melinda M. Protani, et al.. (2013). Dietary folate and related micronutrients, folate-metabolising genes, and ovarian cancer survival. Gynecologic Oncology. 132(3). 566–572. 21 indexed citations
4.
Webb, Penelope M., Torukiri I Ibiebele, Maria Celia B. Hughes, et al.. (2011). Folate and related micronutrients, folate-metabolising genes and risk of ovarian cancer. European Journal of Clinical Nutrition. 65(10). 1133–1140. 30 indexed citations
5.
Amankwah, Ernest K., Qinggang Wang, Ya-Yu Tsai, et al.. (2010). Abstract 2854: Genetic variation in stromal genes decorin and lumican and susceptibility to serous ovarian cancer. Cancer Research. 70(8_Supplement). 2854–2854.
6.
Beesley, Jonathan, Sharon E. Johnatty, Xiaohong Chen, et al.. (2010). No evidence for an association between the earwax-associated polymorphism in ABCC11 and breast cancer risk in Caucasian women. Breast Cancer Research and Treatment. 126(1). 235–239. 9 indexed citations
7.
Goode, Ellen L., Robert A. Vierkant, Catherine M. Phelan, et al.. (2010). Xenobiotic‐Metabolizing gene polymorphisms and ovarian cancer risk. Molecular Carcinogenesis. 50(5). 397–402. 30 indexed citations
8.
Johnatty, Sharon E., Jonathan Beesley, Xiaohong Chen, et al.. (2009). Polymorphisms in the FGF2 Gene and Risk of Serous Ovarian Cancer: Results From the Ovarian Cancer Association Consortium. Twin Research and Human Genetics. 12(3). 269–275. 7 indexed citations
9.
Johnatty, Sharon E., Jonathan Beesley, James Paul, et al.. (2008). ABCB1 ( MDR 1 ) Polymorphisms and Progression-Free Survival among Women with Ovarian Cancer following Paclitaxel/Carboplatin Chemotherapy. Clinical Cancer Research. 14(17). 5594–5601. 73 indexed citations
10.
Johnatty, Sharon E., Jonathan Beesley, Xiaohong Chen, et al.. (2008). The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case–control and family analysis. Breast Cancer Research and Treatment. 115(1). 145–150. 14 indexed citations
11.
Spurdle, Amanda B., Andrew J. Deans, David L. Duffy, et al.. (2008). No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 115(2). 307–313. 9 indexed citations
12.
Johnatty, Sharon E., Amanda B. Spurdle, Jonathan Beesley, et al.. (2007). Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies. Breast Cancer Research and Treatment. 109(1). 91–99. 30 indexed citations
13.
Dowty, James G., Felicity Lose, Mark A. Jenkins, et al.. (2007). The RAD51D E233G variant and breast cancer risk: population-based and clinic-based family studies of Australian women. Breast Cancer Research and Treatment. 112(1). 35–39. 5 indexed citations
14.
Beesley, Jonathan, Susan J. Jordan, Amanda B. Spurdle, et al.. (2007). Association Between Single-Nucleotide Polymorphisms in Hormone Metabolism and DNA Repair Genes and Epithelial Ovarian Cancer: Results from Two Australian Studies and an Additional Validation Set. Cancer Epidemiology Biomarkers & Prevention. 16(12). 2557–2565. 54 indexed citations
15.
Pardhan, Shahina & Jonathan Beesley. (1999). Measurement of corneal curvature in young and older normal subjects.. PubMed. 15(4). 469–74. 20 indexed citations
16.
Beesley, Jonathan, et al.. (1993). Quality management series. How we implemented TQM in our laboratory and our blood bank.. PubMed. 7(3). 217–27. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026